Morepen Laboratories reports 51% jump in export sales revenue in Q4FY19

06 May 2019 Evaluate

Morepen Laboratories has reported export sales revenue up by 51% at Rs 96.41 crore due to high impetus in API business for Q4FY19. The company’s domestic sales revenue up by 13% at Rs 118.84 crore.

Besides, the company’s API sales revenue grew by 34% at Rs 125.48 crore and Home Diagnostics Sales Revenue by 12% at Rs 27.77 crore in Q4FY19 and formulation sales revenue jumped by 30% at Rs 49.35 crore.

Morepen is a well-known pharma company having well equipped Research & Development Centre and is all set to seize the Generic revolution in pharma industry, by filing multiple DMFs and COS for new APIs.

Morepen Laboratories Share Price

62.61 0.63 (1.02%)
29-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.80
Dr. Reddys Lab 1176.25
Cipla 1541.00
Lupin 2067.40
Zydus Lifesciences 887.95
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...